http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108148136-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 |
filingDate | 2015-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108148136-B |
titleOfInvention | anti-VEGF antibodies |
abstract | The present invention discloses antibodies, particularly heavy chain antibodies, more particularly single domain antibodies, that specifically bind Vascular Endothelial Growth Factor (VEGF). Methods of making the antibodies and therapeutic uses are also disclosed. |
priorityDate | 2015-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 602.